pivalopril

structure given in first source

Also Known As:

N-cyclopentyl-N-(3-((2,2-dimethyl-1-oxopropyl)thio)-2-methyl-1-oxypropyl)glycine; RHC 3659; RHC-3659; Glycine, N-cyclopentyl-N-(3-((2,2-dimethyl-1-oxopropyl)thio)-2-methyl-1-oxopropyl)-

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclopentanes: 58
        pivalopril: 1

Experts

1.	Dongmin, Chang: 1 article (12/2020)
2.	Fei, Li: 1 article (12/2020)
3.	Huimei, Huang: 1 article (12/2020)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 12/17/2020 - "In this present study, pivalopril (PP), a clinically used antihypertensive drug, has been verified as a chemosensitizer that extremely improves the sensitivity of breast cancer cells to cDDP. " 12/17/2020 - "Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis."
2.	Neoplasms (Cancer) 12/17/2020 - "Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis."
3.	Neoplasm Metastasis (Metastasis) 12/17/2020 - "Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis."

Related Drugs and Biologics

1.	Antihypertensive Agents (Antihypertensives)